9:38 am, September 30, 2021, local time, Italy -- Salvatore Cincotti, head of TECHNOGENETICS S.R.L. (TGS), a subsidiary of KHB, accepted a live interview lasting about 4 minutes by the Radiotelevisione italiana (RAI) in the northern city of LODI, when he introduced the new rapid saliva test reagent developed by the company, the wider range of application scenarios this technology will bring, as well as the development of TGS.

    According to RAI, the IgM/IgG antibody detect kit (colloidal gold method) against COVID-19 (SARS-CoV-2) provided by TECHNOGENETICS S.R.L, a subsidiary of KHB, has been widely used in testing centers in regions of Campania of Italy.

    On March 17, 2020, KHB also obtained the free marketing certificates of four related products in the European Union, namely the COVID-19 nucleic acid PCR method, the COVID-19 IgM/IgG antibody test ELISA (enzyme-linked immunosorbent assay) and the COVID-19 IgM/IgG antibody test gold-labeled standard method.

    In the face of the changing international epidemic situation, KHB will continue to work side by side with its subsidiary TGS Italy and make greater contributions to the fight against epidemics for mankind by leveraging their respective advantages and accumulation in the field of test reagents!